Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.6, Iss.5, 2005-07, pp. : 481-490

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Tumor Necrosis Factor-a Blockade in Rheumatoid Arthritis: Responders Vs Non Responders

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 3, 2004-07 ,pp. : 361-368

Bentham Science Publishers

Access to resources Recommend Favorite

The Effects of Tumor Necrosis Factor Inhibitors on Cardiovascular Risk in Rheumatoid Arthritis

Current Pharmaceutical Design, Vol. 18, Iss. 11, 2012-04 ,pp. : 1502-1511

Bentham Science Publishers

Access to resources Recommend Favorite

Tumour Necrosis Factor-α Antagonists in the Management of Rheumatoid Arthritis in the Elderly: A Review of Their Efficacy and Safety

By Radovits Beáta J. Kievit Wietske Laan Roland F.J.M.

Drugs & Aging, Vol. 26, Iss. 8, 2009-08 ,pp. : 647-664

Adis International

Access to resources Recommend Favorite

An Overview of Economic Evaluations for Drugs Used in Rheumatoid Arthritis: Focus on Tumour Necrosis Factor- Antagonists

By Nick J. Bansback Dean A. Regier

Drugs, Vol. 65, Iss. 4, 2005-01 ,pp. : 473-496

Adis International

Access to resources Recommend Favorite

Tumour necrosis factor blockade in rheumatoid arthritis

By Breedveld Ferdinand C

Clinical Medicine, Vol. 1, Iss. 2, 2001-03 ,pp. : 107-109

Royal College Of Physicians

Access to resources Recommend Favorite